Publication:
SEOM-TTCC clinical guideline in nasopharynx cancer (2021).

Simple item page
dc.contributor.authorRueda Domínguez, Antonio
dc.contributor.authorCirauqui, Beatriz
dc.contributor.authorGarcía Castaño, Almudena
dc.contributor.authorAlvarez Cabellos, Ruth
dc.contributor.authorCarral Maseda, Alberto
dc.contributor.authorCastelo Fernández, Beatriz
dc.contributor.authorIglesias Rey, Leticia
dc.contributor.authorRubió-Casadevall, Jordi
dc.contributor.authorArrazubi, Virginia
dc.contributor.authorMesía, Ricard
dc.date.accessioned2024-02-27T15:16:05Z
dc.date.available2024-02-27T15:16:05Z
dc.date.issued2022-03-18
dc.description.abstractNasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
dc.format.number4es_ES
dc.format.page670-680es_ES
dc.format.volume24es_ES
dc.identifier.doi10.1007/s12094-022-02814-x
dc.identifier.e-issn1699-3055es_ES
dc.identifier.journalClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexicoes_ES
dc.identifier.otherhttp://hdl.handle.net/10668/21108
dc.identifier.pubmedID35303267es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18783
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectClinical Practice Guidelines
dc.subjectDiagnosis
dc.subjectFollow-up
dc.subjectNasopharyngeal cancer
dc.subjectTreatment
dc.subject.meshHumans
dc.subject.meshNasopharyngeal Carcinoma
dc.subject.meshNasopharyngeal Neoplasms
dc.titleSEOM-TTCC clinical guideline in nasopharynx cancer (2021).
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Collections

IBIMA-Plataforma BIONAND - Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (Andalucía)
IdiSNA - Instituto de Investigación Sanitaria de Navarra (Navarra)